InvestorsHub Logo
icon url

WeeZuhl

05/14/16 6:12 PM

#199994 RE: dr_lowenstein #199986

another puny "generic" with no exclusivity





Actually, I would anticipate an NDA via 505b2. This would allow 3 years exclusivity for the 2 bead pharma ADF while marketing as a "generic" of Embeda. Best of both worlds.
icon url

lasers

05/14/16 6:15 PM

#199996 RE: dr_lowenstein #199986

$ELTP ADF would be a Novel New 505B2 NDA!!!!!! $ELTP NH going for the GOLD and the big bucks!!!!!!!!
icon url

NASDAQ2020

05/14/16 8:17 PM

#200032 RE: dr_lowenstein #199986

Nothing puny about a generic Embeda.
Insurance will pay for that.
Elites generic would be more stable than Embeda itself.